Critical appraisal:Schoen RE, Razzak A, Yu KJ, Berndt SI, Firl K, Riley TL, et al 2015

From Cancer Guidelines Wiki

Risk of bias assessment: cohort study

Subject selection
"New technology" group
Representative of eligible patients.
Comparison group
Representative of eligible patients
Comparability of groups on demographic characteristics and clinical features
Comparable
Measurement of outcomes
Outcome measures blind to technology used
No, but objective measures used
Same method of measurement used across comparison groups
Yes
Completeness of follow-up
Was follow-up complete and were all patients included in the analysis?
Yes (follow-up >95%) or survival analysis using all patients
Overall risk of bias
Low risk of bias Additional comments: Blinding only occurred for death, not incidence of cancer etc.

Median length of follow up was reported (12.5 risk FH, 11.8 no risk)


Jutta's tick icon.png This appraisal has been completed.


Article
Schoen RE, Razzak A, Yu KJ, Berndt SI, Firl K, Riley TL, et al. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. Gastroenterology 2015 Nov;149(6):1438-1445.e1 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26255045.
Assigned to
User:Verity.chadwick
Topic area
Guidelines:Colorectal cancer
Clinical question
Form
Form:Quality appraisal cohort


Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment